Welcome to our dedicated page for AMEREN SEC filings (Ticker: AEE), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on AMEREN's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into AMEREN's regulatory disclosures and financial reporting.
Ameren Corporation director Jamie L. Engstrom reported receiving 1,686 shares of Ameren common stock on 01/05/2026. The Form 4 shows the transaction as an acquisition coded "A" at a reported price of $0 per share, with a footnote stating the award represents director compensation. Following this grant, Engstrom is shown as beneficially owning 1,686 shares of Ameren common stock in a direct ownership capacity.
Ameren Corp director Steven H. Lipstein reported an award of 1,686 shares of common stock on January 5, 2026, as director compensation. The shares were acquired at a reported price of $0 per share, reflecting a stock-based compensation grant rather than an open-market purchase. Following this transaction, Lipstein beneficially owns 37,862 shares of Ameren common stock in direct ownership.
Ameren Corp director reports stock compensation grant. Director Catherine S. Brune reported receiving 1,686 shares of Ameren Corp common stock on 01/05/2026, coded as an acquisition. The shares were granted at a price of $0 per share as part of director compensation, increasing her directly held stake to 27,078 shares of Ameren common stock.
Ameren Corp director Leo S. Mackay Jr. reported receiving 1,686 shares of Ameren common stock on January 5, 2026 as an award classified as director compensation. The shares were acquired at a stated price of $0 per share, indicating they were granted rather than purchased on the open market. Following this grant, he beneficially owns 11,834 Ameren shares in total on a direct basis. This total includes 283 shares accumulated during the first through fourth quarters of 2025 through reinvested dividends.
Ameren Corporation disclosed that director Craig S. Ivey received 1,686 shares of common stock on January 5, 2026 as director compensation. The shares were awarded at a price of $0 per share, indicating they were granted rather than purchased in the market. Following this award, Ivey beneficially owned 16,597 Ameren common shares in direct form. This total includes 416 shares that were acquired during the first through fourth quarters of 2025 through reinvested dividends.
Ameren Corporation director Rafael Flores reported a stock award of 1,686 common shares on January 5, 2026. The shares were acquired at a price of $0 per share as director compensation, reflecting non-cash equity pay.
After this transaction, Flores beneficially owned 15,553 Ameren common shares in direct form. This total includes 96 shares that were accumulated during the fourth quarter of 2025 through reinvested dividends, indicating ongoing participation in dividend reinvestment.
Ameren Corp director Ward H. Dickson reported a stock award of 1,686 shares of Ameren common stock on January 5, 2026 as director compensation. The shares were acquired at a stated price of $0 per share, reflecting a non‑cash equity grant rather than an open-market purchase. After this award, he beneficially owned 18,946 Ameren shares in direct form. This total includes 481 shares accumulated during the first through fourth quarters of 2025 through reinvested dividends, showing that part of his holdings has grown via dividend reinvestment rather than additional transactions.
Ameren Corporation director Ellen M. Fitzsimmons reported a stock award from the company. On January 5, 2026, she acquired 1,686 shares of Ameren common stock at a price of $0 per share, described as director compensation.
After this grant, she beneficially owned 53,026 Ameren shares, held directly. This total includes 143 shares that were acquired during the first through fourth quarters of 2025 through reinvested dividends, showing that a portion of her holdings has been accumulated via dividend reinvestment.
Ameren Corporation director Cynthia J. Brinkley reported receiving 1,686 shares of Ameren common stock on January 5, 2026 as director compensation. The shares were awarded at a price of $0 per share, reflecting a stock-based compensation grant rather than an open-market purchase. Following this award, she beneficially owns 13,494 Ameren shares in total. That total includes 220 shares acquired during the first through fourth quarters of 2025 through reinvested dividends.
Ameren Corporation director Richard J. Harshman reported receiving 1,686 shares of Ameren common stock on January 5, 2026 as an equity award. The shares were acquired at a stated price of $0 per share, consistent with non-cash director compensation. Following this grant, Harshman beneficially owned 22,135 Ameren shares in direct ownership form. A footnote explains that this total includes 71 shares acquired during the fourth quarter of 2025 through reinvested dividends, reflecting ongoing accumulation of stock through the company’s dividend reinvestment process.